Axogen, Inc. (AXGN) › Cash & EquivalentsAxogen, Inc. (AXGN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $282.8K2010: $1.80M2011: $8.19M2012: $13.91M2013: $20.07M2014: $8.22M2015: $25.91M2016: $30.01M2017: $36.51M2018: $24.29M2019: $35.72M2020: $48.77M2021: $32.76M2022: $15.28M2023: $31.02M2024: $27.55M2025: $35.55M$35.55M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$35.55M+29.0%2024$27.55M-11.2%2023$31.02M+103.0%2022$15.28M-53.3%2021$32.76M-32.8%2020$48.77M+36.5%2019$35.72M+47.0%2018$24.29M-33.5%2017$36.51M+21.6%2016$30.01M+15.8%2015$25.91M+215.4%2014$8.22M-59.1%2013$20.07M+44.3%2012$13.91M+69.8%2011$8.19M+355.3%2010$1.80M+536.2%2009$282.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share